Baker Tilly Wealth Management, LLC Cerus Corp Transaction History

Baker Tilly Wealth Management, LLC

  • $220 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 20, 2023
BUY
$1.79 - $2.9 $24,342 - $39,437
13,599 New
13,599 $33,000
Q4 2022

Jan 26, 2023
SELL
$3.38 - $4.22 $7,581 - $9,465
-2,243 Reduced 16.79%
11,117 $0
Q3 2022

Oct 20, 2022
SELL
$3.43 - $5.83 $2,294 - $3,900
-669 Reduced 4.77%
13,360 $48,000
Q2 2022

Jul 28, 2022
BUY
$4.41 - $5.69 $61,867 - $79,825
14,029 New
14,029 $74,000

Others Institutions Holding CERS

# of Institutions
156
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Baker Tilly Wealth Management, LLC Portfolio

Follow Baker Tilly Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Tilly Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baker Tilly Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email